Quidel Corp (QDEL) Tops Q2 EPS by 77c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Quidel Reports Second Quarter 2020 Financial Results
July 30, 2020 4:10 PM EDTSAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2020.
Second Quarter 2020 Highlights
Total revenue increased 86% to $201.8 million, from $108.3 million in the second quarter of 2019. Total sales of COVID-19 products were $109.0 million. Reported GAAP EPS of $1.55 per diluted share in the second quarter of 2020, compared with $0.03 per diluted share in the second quarter of 2019. Reported non-GAAP EPS of $1.86 per... More